Dr. Scott Duncan, MD
Claim this profileGastroOne
Studies Crohn's Disease
Studies Ulcerative Colitis
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Scott Duncan, MD is currently running
Symptom-Based Dosing
for Neonatal Abstinence Syndrome
This clinical trial will help us learn more about how to best care for babies with Neonatal Opioid Withdrawal Syndrome, also called NOWS. Babies with NOWS often have tremors, a hard time sleeping, excessive crying, and trouble feeding. Some babies that have NOWS need medicine. Doctors have two ways of providing medicine that are widely used today: 1. Scheduled opioid taper approach. The baby gets medicine at regular times. As symptoms get better, the amount of medicine the baby gets decreases until the baby no longer needs medicine. This is called a medicine taper. 2. Symptom-based approach. The baby will only get medicine when they show signs of NOWS, instead of at regular times. If the baby is showing no signs of NOWS, no medicine will be given. We are doing the OPTimize NOW study to figure out the best way to give medicine to babies with NOWS.
Recruiting2 awards Phase 3
Immunomodulator Strategy
for Inflammatory Bowel Disease
The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ulcerative colitis \[UC\]) in symptomatic remission with moderate to severe endoscopic inflammation despite optimization of index TIM in a real-world setting.
Recruiting1 award N/A
More about Scott Duncan, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Scott Duncan, MD has experience with
- Pragmatic
- Scheduled Opioid Taper Approach
- Symptom-based Dosing Approach
Breakdown of trials Scott Duncan, MD has run
Crohn's Disease
Ulcerative Colitis
Neonatal Abstinence Syndrome
Substance Withdrawal Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Duncan, MD specialize in?
Scott Duncan, MD focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Scott Duncan, MD currently recruiting for clinical trials?
Yes, Scott Duncan, MD is currently recruiting for 2 clinical trials in Germantown Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Scott Duncan, MD has studied deeply?
Yes, Scott Duncan, MD has studied treatments such as Pragmatic, Scheduled Opioid Taper Approach, Symptom-based Dosing Approach.
What is the best way to schedule an appointment with Scott Duncan, MD?
Apply for one of the trials that Scott Duncan, MD is conducting.
What is the office address of Scott Duncan, MD?
The office of Scott Duncan, MD is located at: GastroOne, Germantown, Tennessee 38138 United States. This is the address for their practice at the GastroOne.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.